Skip to main content
. 2019 May 22;9:7679. doi: 10.1038/s41598-019-44194-3

Figure 7.

Figure 7

Upregulation of MYH9 expression in TRPC6-depleted podocytes. (A) Validation of siRNA knockdown of Trpc6 (siTRPC6) in podocytes using Western blot. (B) Representative traces showing that Ang II-activated [Ca2+]i was inhibited in TRPC6-depleted podocytes compared to control cells (siCTRL). (C) Summary of the results in panel B. (D) Representative traces showing that Ang II (1 μM, 1 h)-induced [Ca2+]i increase was blunted by U73122, the active form of a PLCβ inhibitor, but not by its inactive analog (U73343, 2.5 μM, 1 h). (E) Summary of the results in panel E. (F) Western blot demonstrating the effects of siRNA knockdown of Trpc6 (siTRPC6) on MYH9 upregulation. (G) Schematic representation of the possible signaling pathway leading to podocyte injury by Ang II-mediated MYH9 downregulation. **P < 0.01.